+ Filter

Products

Bispecific Antibody Products

Creative Biolabs is a specialized manufacturer of bispecific antibodies based on our advanced technology and years of experience. We are available to supply all kinds of bispecific antibodies that can be applicated in various research uses.

Bispecific antibodies are now being served as effective therapeutic agents in cancer immunotherapy. Certain recombinant strategies have been developed to synthesize bispecific antibodies, which include single chain variable fragment (scFv)-derived formats such as tandem diabodies, diabodies, BiIEs (bispecific immune cell engagers), and, as well as immunoglobulin G(IgG)-based formats such as two-in-one antibodies.

We offer a number of advanced strategies (recombinant DNA technology, phage display technology etc.) to synthesize the most comprehensive bispecific antibodies above-mentioned with high purity and affinity.

Recombinant Anti-EGFR × Anti-IGF-1R Bispecific Antibody (Triplebody) (TRIAB-MZ013)
- Targets: EGFR & IGF-1R
- Type: Triplebody
- Application: FC, ELISA
Compare

Recombinant Anti-HER3 × Anti-ErbB-2 Bispecific Antibody (Bi-sdAb) (NANO-MZ002)
- Targets: HER3 & ErbB-2
- Type: Bi-sdAb
- Application: PET-CT imaging
Compare

Recombinant Anti-EGFR × Anti-ErbB-3 Bispecific Antibody (Fab₂, PB4522) (FAB-MZ007)
- Targets: EGFR & ErbB-3
- Type: Fab₂
- Application: FC, ADCC Reporter Bioassay
Compare

Recombinant Anti-HER2 × Anti-VEGF Bispecific Antibody (F(ab`)2, bH1-44) (FAB-MZ006)
- Targets: HER2 & VEGF
- Type: F(ab')2
- Application: FC
Compare

Recombinant Anti-EGFR × Anti-ErbB-2 Bispecific Antibody (IgG-IgG) (BSIG-MZ003)
- Targets: EGFR & ErbB-2
- Type: IgG-IgG
- Application: ELISA
Compare

Recombinant Anti-DLL4 × Anti-VEGF Bispecific Antibody (Bi-sdAb, A1) (NANO-MZ001)
- Targets: DLL4 & VEGF
- Type: Bi-sdAb
- Application: ELISA
Compare

Recombinant Anti-D-DT × Anti-MIF Bispecific Antibody (Fab₂, MOR014093) (FAB-MZ005)
- Targets: D-DT & MIF
- Type: Fab₂
- Application: ELISA
Compare

Recombinant Anti-CTLA4 × Anti-PD-1 Bispecific Antibody (Triplebody) (TRIAB-MZ012)
- Targets: CTLA4 & PD-1
- Type: Triplebody
- Application: FC
Compare

Recombinant Anti-MET × Anti-VEGFR-2 Bispecific Antibody (scFv2-Fc) (BSAB-MZ017)
- Targets: MET & VEGFR-2
- Type: scFv2-Fc
- Application: FC
Compare

Recombinant Anti-MET × Anti-VEGF IgG-IgG (MV10A) (BSIG-MZ001)
- Targets: MET & VEGF
- Type: IgG-IgG
- Application: ELISA
Compare

Recombinant Anti-MET × Anti-ErbB-3 Bispecific Antibody (Triplebody) (TRIAB-MZ010)
- Targets: MET & ErbB-3
- Type: Triplebody
- Application: Biacore assay, Cell proliferation assay
Compare

Recombinant Anti-MET × Anti-ErbB-2 Bispecific Antibody (Triplebody) (TRIAB-MZ008)
- Targets: MET & ErbB-2
- Type: Triplebody
- Application: WB, Confocal
Compare

Recombinant Anti-MET × Anti-EpCAM Bispecific Antibody (Tandem Diabody, Ab#5) (TAND-MZ025)
- Targets: MET & EpCAM
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Mouse Anti-MET × Anti-EGFR Bispecific Antibody (Triplebody) (TRIAB-MZ007)
- Targets: MET & EGFR
- Type: Triplebody
- Application: FC
Compare

Recombinant Anti-MET × Anti-EGFR Bispecific Antibody (Triplebody) (TRIAB-MZ006)
- Targets: MET & EGFR
- Type: Triplebody
- Application: WB, ICC
Compare

Recombinant Anti-TNFRSF8 × Anti-ERBB2 Bispecific Antibody (CrossMab) (BSAB-LC004)
- Targets: CD30 & ErbB2
- Type: CrossMab
- Application: ELISA
Compare

Recombinant Anti-ADCYAP1R1 × Anti-CRCP Bispecific Antibody (CrossMab) (BSAB-LC003)
- Targets: PAC1 receptor & CGRP receptor
- Type: CrossMab
- Application: ELISA
Compare

Recombinant Anti-PTPRC × Anti-CD79B Bispecific Antibody (Tandem Diabody) (TAND-LC023)
- Targets: CD45 & CD79
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-Cd300a × Anti-IGHE Bispecific Antibody (Fab₂) (FAB-LC004)
- Targets: CD300A & IgE
- Type: Fab₂
- Application: FC
Compare

Recombinant Mouse Anti-CD300A × Mouse Anti-IGHE Bispecific Antibody (Fab₂) (FAB-LC003)
- Targets: CD300A & IgE
- Type: Fab₂
- Application: FC
Compare

Recombinant Anti-ROR1 × Anti-CD3 Bispecific Antibody (Fab₂) (FAB-LC002)
- Targets: ROR1 & CD3
- Type: Fab₂
- Application: FC
Compare

Recombinant Anti-ROR1 × Anti-CD3 Bispecific Antibody (CrossMab) (BSAB-LC002)
- Targets: ROR1 & CD3
- Type: CrossMab
- Application: FC
Compare

Recombinant Anti-ROR1 × Anti-CD3 Bispecific Antibody (Triplebody) (TRIAB-LC004)
- Targets: ROR1 & CD3
- Type: Triplebody
- Application: FC
Compare

Recombinant Anti-PROM1 × Anti-CD3 Bispecific Antibody (Tandem Diabody) (TAND-LC022)
- Targets: PROM1 & CD3
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-IL5RA × Anti-CD3 Bispecific Antibody (Tandem Diabody) (TAND-LC019)
- Targets: IL5R & CD3
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-IL23R × Anti-CD3 Bispecific Antibody (Tandem Diabody) (TAND-LC017)
- Targets: IL23R & CD3
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-CSPG4 × Anti-CD3 Bispecific Antibody (CrossMab) (BSAB-LC001)
- Targets: MCSP & CD3
- Type: CrossMab
- Application: FC, ELISA
Compare

Recombinant Anti-GPC3 × Anti-CD3 Bispecific Antibody (DAF) (BSAB-LC006)
- Targets: GPC3 & CD3
- Type: DAF
- Application: FC, ELISA
Compare

Recombinant Anti-EGFRvIII × Anti-CD3 Bispecific Antibody (Tandem Diabody) (TAND-LC014)
- Targets: EGFRvIII & CD3
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-CD38 × Anti-CD3 Bispecific Antibody (Triplebody) (TRIAB-LC001)
- Targets: CD38 & CD3
- Type: Triplebody
- Application: SPR
Compare

Recombinant Human Anti-CD33 × Anti-CD3 Bispecific Antibody (Tandem Diabody) (TAND-LC010)
- Targets: CD33 & CD3
- Type: Tandem Diabody
- Application: FC
Compare

Recombinant Anti-CD33 × Anti-CD3 Bispecific Antibody (Tandem Diabody, CD33xCD3 scBsDb) (TAND-LC006)
- Targets: CD33 & CD3
- Type: Tandem Diabody
- Application: FC
Compare

Recombinant Anti-CD22 × Anti-CD79B Bispecific Antibody (Tandem Diabody) (TAND-LC001)
- Targets: CD22 & CD79b
- Type: Tandem Diabody
- Application: FC
Compare

Recombinant Anti-CD19 × Anti-CD64 Bi-specific T-cell engagers (BsFab) (BSAB-L024)
- Targets: CD19 & CD64
- Type: BsFab
Compare

Recombinant Anti-CD74 × Anti-CD22 Bi-specific T-cell engagers (BsFab) (BSAB-L023)
- Targets: CD74 & CD22
- Type: BsFab
Compare

Recombinant Anti-EGFR× Anti-Fcgr1 Bi-specific T-cell engagers (CrossMab) (BSAB-L022)
- Targets: EGFR & Fcgr1
- Type: CrossMab
Compare

Recombinant Anti-CEA× Anti-HSG Bi-specific T-cell engagers (CrossMab) (BSAB-L018)
- Targets: CEA & HSG
- Type: CrossMab
Compare

Recombinant Anti-Ang2× Anti-VEGFA Bi-specific T-cell engagers (CrossMab) (BSAB-L017)
- Targets: Ang2 & VEGFA
- Type: CrossMab
Compare

Recombinant Anti-CD30× Anti-CD16A Bi-specific T-cell engagers (Tandem Diabody) (BSAB-L012)
- Targets: CD30 & CD16A
- Type: Tandem Diabody
Compare

Recombinant Anti-CD19× Anti-CD3 Bi-specific T-cell engagers (Tandem Diabody) (BSAB-L011)
- Targets: CD19 & CD3
- Type: Tandem Diabody
Compare

Recombinant Anti-FcγRIII × Anti-CD33 × Anti-CD19 Bispecific Antibody (Triplebody) (TRIAB-L002)
- Targets: FcγRIII & CD33 & CD19
- Type: Triplebody
- Application: FC
Compare

Recombinant Anti-phenyloxazolone(phOx) × Anti-hen egg lysosome(HEL) Bispecific Antibody (Tandem Diabody) (TAND-L066)
- Targets: phenyloxazolone(phOx) & hen egg lysosome(HEL)
- Type: Tandem Diabody
- Application: FuncS, Immunoassay
Compare

Recombinant Anti-EGFR × Anti-ZnO Bispecific Antibody (Tandem Diabody) (TAND-L065)
- Targets: EGFR & ZnO
- Type: Tandem Diabody
- Application: FuncS, Immunoassay
Compare

Recombinant Anti-C5 × Anti-HRPO Bispecific Antibody (Tandem Diabody) (TAND-L064)
- Targets: C5 & HRPO
- Type: Tandem Diabody
- Application: FuncS, Immunoassay
Compare

Recombinant Anti-CD40 × Anti-Ad fiber knob Bispecific Antibody (Tandem Diabody) (TAND-L063)
- Targets: CD40 & Ad fiber knob
- Type: Tandem Diabody
- Application: FuncS, Gene delivery in gene therapy
Compare

Recombinant Anti-CEA × Anti-Ad fiber knob Bispecific Antibody (Tandem Diabody) (TAND-L062)
- Targets: CEA & Ad fiber knob
- Type: Tandem Diabody
- Application: FuncS, Gene delivery in gene therapy
Compare

Recombinant Anti-TROP-2 × Anti-HSG Bispecific Antibody (Tandem Diabody) (TAND-L061)
- Targets: TROP-2 & HSG
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-FN1 × Anti-HSG Bispecific Antibody (Tandem Diabody) (TAND-L060)
- Targets: FN1 & HSG
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-FOLR1 × Anti-CD3 Bispecific Antibody (Tandem Diabody) (TAND-L059)
- Targets: FOLR1 & CD3
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-Thyroglobulin × Anti-TPO Bispecific Antibody (Tandem Diabody) (TAND-L058)
- Targets: Thyroglobulin & TPO
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-S protein × Anti-pre S2 protein Bispecific Antibody (Tandem Diabody) (TAND-L057)
- Targets: S protein & pre S2 protein
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-CD28 × Anti-melanoma-associated proteoglycan Bispecific Antibody (Tandem Diabody) (TAND-L056)
- Targets: CD28 & melanoma-associated proteoglycan
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-TCR(Vβ 8 ) × Anti-M2 Bispecific Antibody (Tandem Diabody) (TAND-L055)
- Targets: TCR(Vβ 8 ) & M2
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-FcγRI × Anti-LPA Bispecific Antibody (Tandem Diabody) (TAND-L054)
- Targets: FcγRI & LPA
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-FcγRIIB × Anti-LPA Bispecific Antibody (Tandem Diabody) (TAND-L053)
- Targets: FcγRIIB & LPA
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-EGFR × Anti-IGFR Bispecific Antibody (Tandem Diabody) (TAND-L052)
- Targets: EGFR & IGFR
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-FcγRIII × Anti-CD30 Bispecific Antibody (Tandem Diabody) (TAND-L051)
- Targets: FcγRIII & CD30
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-PLAP × Anti-CD3 Bispecific Antibody (Tandem Diabody) (TAND-L050)
- Targets: PLAP & CD3
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-EGFR × Anti-CD3 Bispecific Antibody (Tandem Diabody) (TAND-L049)
- Targets: EGFR & CD3
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-PDGFR2 × Anti-VEGFR2 Bispecific Antibody (Tandem Diabody) (TAND-L048)
- Targets: PDGFR2 & VEGFR2
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-Melanoma-associated proteoglycan × Anti-CD28 Bispecific Antibody (Tandem Diabody) (TAND-L047)
- Targets: Melanoma-associated proteoglycan & CD28
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-VEGFR2 × Anti-VEGFR3 Bispecific Antibody (Tandem Diabody) (TAND-L046)
- Targets: VEGFR2 & VEGFR3
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-EPCAM × Anti-CD3 Bispecific Antibody (Tandem Diabody) (TAND-L045)
- Targets: EPCAM & CD3
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-CD33 × Anti-FcγRIII Bispecific Antibody (Tandem Diabody) (TAND-L044)
- Targets: CD33 & FcγRIII
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-VEGF × Anti-VEGF-B Bispecific Antibody (Tandem Diabody) (TAND-L043)
- Targets: VEGF & VEGF-B
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-Ang2 × Anti-VEGFA Bispecific Antibody (Tandem Diabody) (TAND-L042)
- Targets: Ang2 & VEGFA
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-NG2 × Anti-CD28 Bispecific Antibody (Tandem Diabody) (TAND-L041)
- Targets: NG2 & CD28
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-CD19 × Anti-CD47 Bispecific Antibody (Tandem Diabody) (TAND-L040)
- Targets: CD19 & CD47
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-CD20 × Anti-CD22 Bispecific Antibody (Tandem Diabody) (TAND-L039)
- Targets: CD20 & CD22
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-CD22 × Anti-CD19 Bispecific Antibody (Tandem Diabody) (TAND-L038)
- Targets: CD22 & CD19
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-DKKl × Anti-SOST Bispecific Antibody (Tandem Diabody) (TAND-L037)
- Targets: DKKl & SOST
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-gpA33 × Anti-CD3 Bispecific Antibody (Tandem Diabody) (TAND-L036)
- Targets: gpA33 & CD3
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-Myosin × Anti-CD45 Bispecific Antibody (Tandem Diabody) (TAND-L035)
- Targets: Myosin & CD45
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-CD47 × Anti-SIRPA Bispecific Antibody (Tandem Diabody) (TAND-L034)
- Targets: CD47 & SIRPA
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-IL4 × Anti-IL13 Bispecific Antibody (Tandem Diabody) (TAND-L033)
- Targets: IL4 & IL13
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-EGFR × Anti-HER3 Bispecific Antibody (Tandem Diabody) (TAND-L032)
- Targets: EGFR & HER3
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-AR × Anti-DNA Bispecific Antibody (Tandem Diabody) (TAND-L031)
- Targets: AR & DNA
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-VEGF × Anti-ANG2 Bispecific Antibody (Tandem Diabody) (TAND-L030)
- Targets: VEGF & ANG2
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-IL-23 × Anti-IL-6 Bispecific Antibody (Tandem Diabody) (TAND-L029)
- Targets: IL-23 & IL-6
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-EGFR × Anti-HER2 Bispecific Antibody (Tandem Diabody) (TAND-L028)
- Targets: EGFR & HER2
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-CD20 × Anti-CD28 Bispecific Antibody (Tandem Diabody) (TAND-L027)
- Targets: CD20 & CD28
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-GD2 × Anti-FcγRIII Bispecific Antibody (Tandem Diabody) (TAND-L026)
- Targets: GD2 & FcγRIII
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-FcαRI × Anti-HLA class II Bispecific Antibody (Tandem Diabody) (TAND-L025)
- Targets: FcαRI & HLA class II
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-IGFR × Anti-HER3 Bispecific Antibody (Tandem Diabody) (TAND-L024)
- Targets: IGFR & HER3
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-HER2 × Anti-HER3 Bispecific Antibody (Tandem Diabody) (TAND-L023)
- Targets: HER2 & HER3
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-VEGF × Anti-PDGFRβ Bispecific Antibody (Tandem Diabody) (TAND-L022)
- Targets: VEGF & PDGFRβ
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-IL-15 × Anti-TNFSF9 Bispecific Antibody (Tandem Diabody) (TAND-L021)
- Targets: IL-15 & TNFSF9
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-VEGF × Anti-FGF Bispecific Antibody (Tandem Diabody) (TAND-L020)
- Targets: VEGF & FGF
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-EGFR × Anti-MET Bispecific Antibody (Tandem Diabody) (TAND-L019)
- Targets: EGFR & MET
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-IL-17A × Anti-IL-23 Bispecific Antibody (Tandem Diabody) (TAND-L018)
- Targets: IL-17A & IL-23
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-VEGF × Anti-OPN Bispecific Antibody (Tandem Diabody) (TAND-L017)
- Targets: VEGF & OPN
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-IL17A × Anti-TNF Bispecific Antibody (Tandem Diabody) (TAND-L016)
- Targets: IL17A & TNF
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-Betv1 × Anti-Feld1 Bispecific Antibody (Tandem Diabody) (TAND-L015)
- Targets: Betv1 & Feld1
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-PSCA × Anti-CD8 Bispecific Antibody (Tandem Diabody) (TAND-L014)
- Targets: PSCA & CD8
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-VEGF × Anti-HER2 Bispecific Antibody (Tandem Diabody) (TAND-L013)
- Targets: VEGF & HER2
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-HER1 × Anti-HER3 Bispecific Antibody (Tandem Diabody) (TAND-L012)
- Targets: HER1 & HER3
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-HER3 × Anti-EGFR Bispecific Antibody (Tandem Diabody) (TAND-L011)
- Targets: HER3 & EGFR
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-FXIa × Anti-FX Bispecific Antibody (Tandem Diabody) (TAND-L010)
- Targets: FXIa & FX
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-CD40 × Anti-CD28 Bispecific Antibody (Tandem Diabody) (TAND-L009)
- Targets: CD40 & CD28
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

Recombinant Anti-MET × Anti-EGFR Bispecific Antibody (Tandem Diabody) (TAND-L008)
- Targets: MET & EGFR
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare

More Infomation

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag

For Research Use Only. Not For Clinical Use.